Use of Natural Language Processing to Extract Clinical Cancer Phenotypes from Electronic Medical Records.

Current models for correlating electronic medical records with -omics data largely ignore clinical text, which is an important source of phenotype information for cancer patients. This data convergence has the potential to reveal new insights about cancer initiation, progression, metastasis, and response to treatment. Insights from this real-world data will catalyze clinical care, research, and regulatory activities. Natural language processing (NLP) methods are needed to extract these rich cancer phenotypes from clinical text. Here, we review the advances of NLP and information extraction methods relevant to oncology based on publications from PubMed as well as NLP and machine learning conference proceedings in the last 3 years. Given the interdisciplinary nature of the fields of oncology and information extraction, this analysis serves as a critical trail marker on the path to higher fidelity oncology phenotypes from real-world data.

[1]  Morten Nielsen,et al.  The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding , 2009, Bioinform..

[2]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[3]  Collin Tokheim,et al.  Evaluation of machine learning methods to predict peptide binding to MHC Class I proteins , 2017, bioRxiv.

[4]  Alessandro Sette,et al.  Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method , 2005, BMC Bioinformatics.

[5]  Kam Y. J. Zhang,et al.  Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity , 2008, Proceedings of the National Academy of Sciences.

[6]  J. Gartner,et al.  Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers. , 2019, Cancer discovery.

[7]  Kate Voss,et al.  Full-stack genomics pipelining with GATK4 + WDL + Cromwell , 2017 .

[8]  A. Spurdle,et al.  Most common 'sporadic' cancers have a significant germline genetic component. , 2014, Human molecular genetics.

[9]  Morten Nielsen,et al.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11 , 2008, Nucleic Acids Res..

[10]  Shyam Visweswaran,et al.  Automated annotation and classification of BI-RADS assessment from radiology reports , 2017, J. Biomed. Informatics.

[11]  L. Skarsgard,et al.  Dose dependence of the oxygen enhancement ratio (OER) in radiation inactivation of Chinese hamster V79-171 cells. , 1991, Radiation Research.

[12]  Joshy George,et al.  Whole–genome characterization of chemoresistant ovarian cancer , 2015, Nature.

[13]  Hong Yu,et al.  Structured prediction models for RNN based sequence labeling in clinical text , 2016, EMNLP.

[14]  The problem with neoantigen prediction , 2017, Nature Biotechnology.

[15]  Bjoern Peters,et al.  Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.

[16]  M. Ringnér,et al.  Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma , 2017, Nature Communications.

[17]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[18]  Barbara L. Smith,et al.  Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions , 2018, Breast Cancer Research and Treatment.

[19]  G. Gallia,et al.  Multiple resections for patients with glioblastoma: prolonging survival. , 2013, Journal of neurosurgery.

[20]  C. Dominici,et al.  Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines , 2019, Journal of Endocrinological Investigation.

[21]  Anton Nekrutenko,et al.  Ten Simple Rules for Reproducible Computational Research , 2013, PLoS Comput. Biol..

[22]  Ji-Xin Cheng,et al.  Ex vivo and in vivo imaging of myelin fibers in mouse brain by coherent anti-Stokes Raman scattering microscopy. , 2008, Optics express.

[23]  Robert E. Schapire,et al.  The Boosting Approach to Machine Learning An Overview , 2003 .

[24]  Joshua A. Bittker,et al.  Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset. , 2015, Cancer discovery.

[25]  Geoffrey E. Hinton,et al.  Deep Learning , 2015, Nature.

[26]  R G Dale,et al.  The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. , 1985, The British journal of radiology.

[27]  J. Sarkaria,et al.  Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. , 2018, The Lancet. Oncology.

[28]  P. Marynen,et al.  Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. , 2005, Gastroenterology.

[29]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[30]  James Pustejovsky,et al.  SemEval-2016 Task 12: Clinical TempEval , 2016, NAACL 2016.

[31]  J. Manson,et al.  Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer. , 2007, Cancer research.

[32]  Christopher R. Cabanski,et al.  cDNA hybrid capture improves transcriptome analysis on low-input and archived samples. , 2014, The Journal of molecular diagnostics : JMD.

[33]  Adam P Dicker,et al.  Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. , 2016, The Lancet. Oncology.

[34]  T. Mikkelsen,et al.  Identification of regions of normal grey matter and white matter from pathologic glioblastoma and necrosis in frozen sections using Raman imaging , 2015, Journal of Neuro-Oncology.

[35]  Stephen T. C. Wong,et al.  Chemically-selective imaging of brain structures with CARS microscopy. , 2007, Optics express.

[36]  Alastair J. King,et al.  Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors. , 2013, ACS medicinal chemistry letters.

[37]  Abhishek Pandey,et al.  Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review , 2017, J. Biomed. Informatics.

[38]  D. Tindall,et al.  Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation. , 2015, Cancer research.

[39]  Mithat Gönen,et al.  Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer , 2017, Nature.

[40]  Timothy L. Tickle,et al.  STAR-Fusion: Fast and Accurate Fusion Transcript Detection from RNA-Seq , 2017, bioRxiv.

[41]  E. Jaffee,et al.  Targeting neoantigens to augment antitumour immunity , 2017, Nature Reviews Cancer.

[42]  V. Lewis,et al.  Current and future therapeutic approaches for osteosarcoma , 2018, Expert review of anticancer therapy.

[43]  E. Birney,et al.  The topography of mutational processes in breast cancer genomes , 2016, Nature Communications.

[44]  Geoffrey S. Tobias,et al.  Family history of cancer and risk of pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan) , 2010, International journal of cancer.

[45]  Ash A. Alizadeh,et al.  Profiling Tumor Infiltrating Immune Cells with CIBERSORT. , 2018, Methods in molecular biology.

[46]  D. Albanes,et al.  Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. , 2005, JAMA.

[47]  A. Lazar,et al.  Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma , 2014, BMC Clinical Pathology.

[48]  G. Getz,et al.  Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer , 2017, Nature Communications.

[49]  Marc R. Birtwistle,et al.  Drug response consistency in CCLE and CGP , 2016, Nature.

[50]  Johannes G. Reiter,et al.  Minimal functional driver gene heterogeneity among untreated metastases , 2018, Science.

[51]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[52]  Bjoern Peters,et al.  HLA Class I Alleles Are Associated with Peptide-Binding Repertoires of Different Size, Affinity, and Immunogenicity , 2013, The Journal of Immunology.

[53]  Li Ding,et al.  Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. , 2014, Cell reports.

[54]  Angelika Unterhuber,et al.  Imaging ex vivo healthy and pathological human brain tissue with ultra-high-resolution optical coherence tomography. , 2005, Journal of biomedical optics.

[55]  J. Fujimoto,et al.  Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. , 2000, Neoplasia.

[56]  Paul Fockens,et al.  International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer , 2012, Gut.

[57]  J. Torres-Roca,et al.  Predicting response to clinical radiotherapy: past, present, and future directions. , 2008, Cancer control : journal of the Moffitt Cancer Center.

[58]  Robert Gentleman,et al.  Statistical Applications in Genetics and Molecular Biology , 2005 .

[59]  Christoph U. Lehmann,et al.  Electronic Health Record Interactions through Voice: A Review , 2018, Applied Clinical Informatics.

[60]  Jennifer G. Abelin,et al.  Mass Spectrometry Profiling of HLA‐Associated Peptidomes in Mono‐allelic Cells Enables More Accurate Epitope Prediction , 2017, Immunity.

[61]  S. Brunak,et al.  Prediction of proteasome cleavage motifs by neural networks. , 2002, Protein engineering.

[62]  A. Quiñones‐Hinojosa,et al.  Advances in Brain Tumor Surgery for Glioblastoma in Adults , 2017, Brain sciences.

[63]  Luca Toschi,et al.  Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. , 2010, Cancer cell.

[64]  Olivier Elemento,et al.  AGFusion: annotate and visualize gene fusions , 2016, bioRxiv.

[65]  Joshua C. Gilbert,et al.  An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules , 2013, Cell.

[66]  Steven Eschrich,et al.  Prediction of radiation sensitivity using a gene expression classifier. , 2005, Cancer research.

[67]  M. Nielsen,et al.  NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data , 2017, The Journal of Immunology.

[68]  A. Goto,et al.  Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort. , 2018, Gastroenterology.

[69]  Hongfang Liu,et al.  CLAMP – a toolkit for efficiently building customized clinical natural language processing pipelines , 2017, J. Am. Medical Informatics Assoc..

[70]  Benjamin Schubert,et al.  OptiType: precision HLA typing from next-generation sequencing data , 2014, Bioinform..

[71]  Kevin Petrecca,et al.  Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma , 2012, Journal of Neuro-Oncology.

[72]  David Gfeller,et al.  Current tools for predicting cancer-specific T cell immunity , 2016, Oncoimmunology.

[73]  T. Hastie,et al.  Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data. , 2018, Journal of the National Cancer Institute.

[74]  Peter Spyns Natural Language Processing in Medicine: An Overview , 1996, Methods of Information in Medicine.

[75]  Felix Y. Feng,et al.  Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer , 2015, Clinical Cancer Research.

[76]  Nasrollah Erfani,et al.  Structural vaccinology considerations for in silico designing of a multi-epitope vaccine. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[77]  D. Elder,et al.  The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. , 2009, The American journal of pathology.

[78]  David E Larson,et al.  Using VarScan 2 for Germline Variant Calling and Somatic Mutation Detection , 2013, Current protocols in bioinformatics.

[79]  L. Choo-Smith,et al.  Discriminating Vital Tumor from Necrotic Tissue in Human Glioblastoma Tissue Samples by Raman Spectroscopy , 2002, Laboratory Investigation.

[80]  A. McKenna,et al.  The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. , 2014, Cancer discovery.

[81]  Malachi Griffith,et al.  pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens , 2020, Cancer Immunology Research.

[82]  Shang Gao,et al.  Hierarchical attention networks for information extraction from cancer pathology reports , 2017, J. Am. Medical Informatics Assoc..

[83]  Yusuke Nakamura,et al.  Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer , 2014, Nature Genetics.

[84]  Florian Engert,et al.  Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency , 2015, Nature Communications.

[85]  Kenneth H. Buetow,et al.  Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format , 2022 .

[86]  Zoltan Szallasi,et al.  MuPeXI: prediction of neo-epitopes from tumor sequencing data , 2017, Cancer Immunology, Immunotherapy.

[87]  Jin Zhang,et al.  INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery , 2016, Bioinform..

[88]  Hua Xu,et al.  Data from clinical notes: a perspective on the tension between structure and flexible documentation , 2011, J. Am. Medical Informatics Assoc..

[89]  J. Hammerbacher,et al.  Vaxrank: A computational tool for designing personalized cancer vaccines , 2017, bioRxiv.

[90]  T. Mikkelsen,et al.  Raman spectroscopy to distinguish grey matter, necrosis, and glioblastoma multiforme in frozen tissue sections , 2014, Journal of Neuro-Oncology.

[91]  Brian S. Finkelman,et al.  A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes. , 2017 .

[92]  Henry Brem,et al.  Supratentorial Glioblastoma Multiforme: The Role of Surgical Resection Versus Biopsy Among Older Patients , 2010, Annals of Surgical Oncology.

[93]  Eric Fosler-Lussier,et al.  Automatic data source identification for clinical trial eligibility criteria resolution , 2016, AMIA.

[94]  Myles A Brown,et al.  An Integrative Pharmacogenomic Approach Identifies Two-drug Combination Therapies for Personalized Cancer Medicine , 2016, Scientific Reports.

[95]  Alan R. Aronson,et al.  Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program , 2001, AMIA.

[96]  E. Lankenau,et al.  Imaging of human brain tumor tissue by near-infrared laser coherence tomography , 2009, Acta Neurochirurgica.

[97]  Eytan Ruppin,et al.  Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality , 2014, Cell.

[98]  S. Salzberg,et al.  TopHat-Fusion: an algorithm for discovery of novel fusion transcripts , 2011, Genome Biology.

[99]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[100]  J. Manson,et al.  A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. , 2013, Journal of the National Cancer Institute.

[101]  Habib Zaidi,et al.  Quantitative analysis of MRI-guided attenuation correction techniques in time-of-flight brain PET/MRI , 2016, NeuroImage.

[102]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[103]  O. Lund,et al.  NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ , 2013, Immunogenetics.

[104]  Masaya Suenaga,et al.  Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[105]  J. Manson,et al.  Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[106]  Todd Hollon,et al.  Improving the accuracy of brain tumor surgery via Raman-based technology. , 2016, Neurosurgical focus.

[107]  Hsin-Hsiung Huang,et al.  Comparing logistic regression, support vector machines, and permanental classification methods in predicting hypertension , 2014, BMC Proceedings.

[108]  B. Park,et al.  Mutation of the PIK3CA oncogene in human cancers , 2006, British Journal of Cancer.

[109]  A. Giese,et al.  Time‐domain and spectral‐domain optical coherence tomography in the analysis of brain tumor tissue , 2006, Lasers in surgery and medicine.

[110]  M. Knowles,et al.  Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer , 2007, Oncogene.

[111]  Hong Yu,et al.  Bidirectional RNN for Medical Event Detection in Electronic Health Records , 2016, NAACL.

[112]  Alex Rubinsteyn,et al.  MHCflurry: Open-Source Class I MHC Binding Affinity Prediction. , 2018, Cell systems.

[113]  Raffaele Pezzilli,et al.  Common variation at 2 p 13 . 3 , 3 q 29 , 7 p 13 and 17 q 25 . 1 associated with susceptibility to pancreatic cancer , 2022 .

[114]  Morten Nielsen,et al.  Pan-Specific Prediction of Peptide–MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity , 2016, The Journal of Immunology.

[115]  Hinrich Schütze,et al.  Introduction to information retrieval , 2008 .

[116]  J. Gartner,et al.  Immunogenicity of somatic mutations in human gastrointestinal cancers , 2015, Science.

[117]  John N Weinstein,et al.  Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. , 2008, Cancer research.

[118]  A. Carr,et al.  CRL4Wdr70 regulates H2B monoubiquitination and facilitates Exo1-dependent resection , 2016, Nature Communications.

[119]  Xingde Li,et al.  Robust and fast characterization of OCT-based optical attenuation using a novel frequency-domain algorithm for brain cancer detection , 2017, Scientific Reports.

[120]  K. Kohn,et al.  DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas. , 1977, Cancer research.

[121]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[122]  Kristen Howell,et al.  Improving Feature Extraction for Pathology Reports with Precise Negation Scope Detection , 2018, COLING.

[123]  Herbert Yu,et al.  Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. , 2015, American journal of epidemiology.

[124]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[125]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[126]  Erik Cambria,et al.  Recent Trends in Deep Learning Based Natural Language Processing , 2017, IEEE Comput. Intell. Mag..

[127]  Geoffrey S. Tobias,et al.  Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. , 2009, American journal of epidemiology.

[128]  R. Karchin,et al.  CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers. , 2019, Cell systems.

[129]  H. Ishwaran,et al.  Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer , 2018, Cancer Immunology Research.

[130]  Alison Callahan,et al.  Performing an Informatics Consult: Methods and Challenges. , 2018, Journal of the American College of Radiology : JACR.

[131]  J. Gartner,et al.  Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens , 2016, Cancer Immunology Research.

[132]  Alison P. Klein,et al.  An Absolute Risk Model to Identify Individuals at Elevated Risk for Pancreatic Cancer in the General Population , 2013, PloS one.

[133]  Mi Ni Huang,et al.  In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors , 2017, bioRxiv.

[134]  Gregory W. Auner,et al.  Raman molecular imaging of brain frozen tissue sections , 2014, Journal of Neuro-Oncology.

[135]  M. Makary,et al.  Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers , 2017, Proceedings of the National Academy of Sciences.

[136]  C. Klabunde,et al.  Linking Physician Characteristics and Medicare Claims Data: Issues in Data Availability, Quality, and Measurement , 2002, Medical care.

[137]  Keith D. Paulsen,et al.  δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. , 2011, Neuro-oncology.

[138]  L. Bernstein,et al.  Intraoperative brain cancer detection with Raman spectroscopy in humans , 2015, Science Translational Medicine.

[139]  Christian Dehlendorff,et al.  Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer , 2018, Oncotarget.

[140]  V. Velculescu,et al.  High-throughput prediction of MHC Class I and Class II neoantigens with MHCnuggets , 2019, bioRxiv.

[141]  Peter Kraft,et al.  Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer , 2018, Nature Communications.

[142]  Alan R. Aronson,et al.  An overview of MetaMap: historical perspective and recent advances , 2010, J. Am. Medical Informatics Assoc..

[143]  M. McCarter,et al.  Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma. , 2015, JAMA surgery.

[144]  Larry Norton,et al.  Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.

[145]  J. Mesirov,et al.  Integrative radiogenomic profiling of squamous cell lung cancer. , 2013, Cancer research.

[146]  J. Manson,et al.  Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. , 2013, Journal of the National Cancer Institute.

[147]  D. Haussler,et al.  ProTECT—Prediction of T-Cell Epitopes for Cancer Therapy , 2019, bioRxiv.

[148]  B. Fertil,et al.  Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. , 1985, International journal of radiation oncology, biology, physics.

[149]  S. Molyneux,et al.  Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma , 2018, Oncogene.

[150]  Shuguang Huang,et al.  Comparing statistical methods for quantifying drug sensitivity based on in vitro dose-response assays. , 2012, Assay and drug development technologies.

[151]  Kai Ye,et al.  Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..

[152]  George Coukos,et al.  The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands , 2018, The Journal of Immunology.

[153]  E. Prosperi,et al.  CREBBP and p300 lysine acetyl transferases in the DNA damage response , 2017, Cellular and Molecular Life Sciences.

[154]  O. Lund,et al.  NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.

[155]  G. Giaever,et al.  DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. , 2013, Chemistry & biology.

[156]  Olivier Ferret,et al.  Neural Architecture for Temporal Relation Extraction: A Bi-LSTM Approach for Detecting Narrative Containers , 2017, ACL.

[157]  Crispin J. Miller,et al.  Investigation of Radiosensitivity Gene Signatures in Cancer Cell Lines , 2014, PloS one.

[158]  T. Schumacher,et al.  Neoantigens in cancer immunotherapy , 2015, Science.

[159]  S. Biswal,et al.  Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. , 2010, Antioxidants & redox signaling.

[160]  I. Nookaew,et al.  Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods , 2013, Nucleic acids research.

[161]  Chen Lin,et al.  Improving Temporal Relation Extraction with Training Instance Augmentation , 2016, BioNLP@ACL.

[162]  L. Jensen,et al.  Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation* , 2015, Molecular & Cellular Proteomics.

[163]  Bjoern Peters,et al.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.

[164]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[165]  Benjamin Schubert,et al.  Designing string-of-beads vaccines with optimal spacers , 2016, Genome Medicine.

[166]  J. Baek,et al.  Early experience with Watson for oncology in Korean patients with colorectal cancer , 2019, PloS one.

[167]  S A Boppart,et al.  Optical coherence tomography for neurosurgical imaging of human intracortical melanoma. , 1998, Neurosurgery.

[168]  Dirk Verellen,et al.  Innovations in image-guided radiotherapy , 2008, Nature Reviews Cancer.

[169]  Michael C. Heinold,et al.  The landscape of genomic alterations across childhood cancers , 2018, Nature.

[170]  R. Langer,et al.  The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. , 2003, Annals of epidemiology.

[171]  Martin Villiger,et al.  Automatic classification of atherosclerotic plaques imaged with intravascular OCT. , 2016, Biomedical optics express.

[172]  Jeremy L Warner,et al.  Automating the Determination of Prostate Cancer Risk Strata From Electronic Medical Records. , 2017, JCO clinical cancer informatics.

[173]  O. Lund,et al.  novel sequence representations Reliable prediction of T-cell epitopes using neural networks with , 2003 .

[174]  Laurent Mahieu-Williame,et al.  Two-peaked 5-ALA-induced PpIX fluorescence emission spectrum distinguishes glioblastomas from low grade gliomas and infiltrative component of glioblastomas , 2013, Biomedical optics express.

[175]  O. Kallioniemi,et al.  FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data , 2014, bioRxiv.

[176]  Dima Suki,et al.  Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[177]  N. Blüthgen,et al.  Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids , 2017, The Journal of cell biology.

[178]  Henry Brem,et al.  Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. , 2014, Neuro-oncology.

[179]  E. McVeigh,et al.  Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography , 2015, Science Translational Medicine.

[180]  Chen-Yang Shen,et al.  FGFR2 regulates Mre11 expression and double-strand break repair via the MEK-ERK-POU1F1 pathway in breast tumorigenesis. , 2015, Human molecular genetics.

[181]  Adam Kiezun,et al.  Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma , 2014, Proceedings of the National Academy of Sciences.

[182]  M. Snuderl,et al.  Rapid Intraoperative Diagnosis of Pediatric Brain Tumors Using Stimulated Raman Histology. , 2018, Cancer research.

[183]  G A Colditz,et al.  Physical Activity, Obesity, and Risk for Colon Cancer and Adenoma in Men , 1995, Annals of Internal Medicine.

[184]  Gonçalo R. Abecasis,et al.  Unified representation of genetic variants , 2015, Bioinform..

[185]  Geoffrey S. Tobias,et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.

[186]  Qingxia Chen,et al.  The therapy is making me sick: how online portal communications between breast cancer patients and physicians indicate medication discontinuation , 2018, J. Am. Medical Informatics Assoc..

[187]  Alfredo Quinones-Hinojosa,et al.  The Value of Extent of Resection of Glioblastomas: Clinical Evidence and Current Approach , 2014, Current Neurology and Neuroscience Reports.

[188]  M. Nielsen,et al.  The Length Distribution of Class I–Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele–Specific Binding Preference , 2016, The Journal of Immunology.

[189]  S. Leivonen,et al.  Hypoxia-activated Smad3-specific Dephosphorylation by PP2A* , 2009, The Journal of Biological Chemistry.

[190]  Martin E. Fernandez-Zapico,et al.  Faculty Opinions recommendation of Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. , 2015 .

[191]  Chen Lin,et al.  Temporal Annotation in the Clinical Domain , 2014, TACL.

[192]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[193]  Jeffrey E. Lee,et al.  A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma , 2018, Clinical Cancer Research.

[194]  Maurizio Zanetti,et al.  Neoantigen prediction and the need for validation , 2017, Nature Biotechnology.

[195]  Bentzen,et al.  Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. , 1994, Seminars in radiation oncology.

[196]  Yoram Singer,et al.  BoosTexter: A Boosting-based System for Text Categorization , 2000, Machine Learning.

[197]  Michael Gertz,et al.  Multilingual and cross-domain temporal tagging , 2012, Language Resources and Evaluation.

[198]  J. Brooks,et al.  New Paradigms for Patient-Centered Outcomes Research in Electronic Medical Records: An Example of Detecting Urinary Incontinence Following Prostatectomy , 2016, EGEMS.

[199]  Xinyu Zhang,et al.  CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens , 2017, Bioinform..

[200]  Li Ding,et al.  Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. , 2018, Cell systems.

[201]  Hong-Jun Yoon,et al.  Coarse-to-fine multi-task training of convolutional neural networks for automated information extraction from cancer pathology reports , 2018, 2018 IEEE EMBS International Conference on Biomedical & Health Informatics (BHI).

[202]  Anthony N. Nguyen,et al.  Automatic Diagnosis Coding of Radiology Reports: A Comparison of Deep Learning and Conventional Classification Methods , 2017, BioNLP.

[203]  Alfredo Quinones-Hinojosa,et al.  When gross total resection of a glioblastoma is possible, how much resection should be achieved? , 2014, World neurosurgery.

[204]  R. Emerson,et al.  Radiotherapy induces responses of lung cancer to CTLA-4 blockade , 2018, Nature Medicine.

[205]  Y. Asmann,et al.  High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma , 2017, Blood Cancer Journal.

[206]  P. Lønning,et al.  Genomic Evolution of Breast Cancer Metastasis and Relapse , 2017, Cancer cell.

[207]  Marco Foiani,et al.  Regulation of DNA repair throughout the cell cycle , 2008, Nature Reviews Molecular Cell Biology.

[208]  P. Agius,et al.  Immunogenic neoantigens derived from gene fusions stimulate T cell responses , 2019, Nature Medicine.

[209]  T. McMillan,et al.  The radiobiology of human cells and tissues. In vitro radiosensitivity. The picture has changed in the 1980s. , 1989, International journal of radiation biology.

[210]  B. Wouters,et al.  Apoptosis, p53, and tumor cell sensitivity to anticancer agents. , 1999, Cancer research.

[211]  Antonio Pertusa,et al.  Learning Eligibility in Cancer Clinical Trials using Deep Neural Networks , 2018, Applied Sciences.

[212]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[213]  C. Wirtz,et al.  Histopathological Insights on Imaging Results of Intraoperative Magnetic Resonance Imaging, 5-Aminolevulinic Acid, and Intraoperative Ultrasound in Glioblastoma Surgery , 2017, Neurosurgery.

[214]  B Palcic,et al.  Reduced oxygen enhancement ratio at low doses of ionizing radiation. , 1984, Radiation research.

[215]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[216]  David Gfeller,et al.  Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity , 2017, bioRxiv.

[217]  T. Nakano,et al.  Inter-assay precision of clonogenic assays for radiosensitivity in cancer cell line A549 , 2018, Oncotarget.

[218]  Fupan Yao,et al.  Tissue specificity of in vitro drug sensitivity , 2016, bioRxiv.

[219]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[220]  Emanuel J. V. Gonçalves,et al.  A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.

[221]  David L. Masica,et al.  Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure. , 2016, Cancer research.

[222]  Zoubin Ghahramani,et al.  A Theoretically Grounded Application of Dropout in Recurrent Neural Networks , 2015, NIPS.

[223]  J. Willmann,et al.  Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma , 2018, Clinical Cancer Research.

[224]  Wen-wai Yim,et al.  Natural Language Processing in Oncology: A Review. , 2016, JAMA oncology.

[225]  Elaine R. Mardis,et al.  Applications of Immunogenomics to Cancer , 2017, Cell.

[226]  Michael C. Rusch,et al.  CREST maps somatic structural variation in cancer genomes with base-pair resolution , 2011, Nature Methods.

[227]  Moriah H Nissan,et al.  OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.

[228]  Lawrence T. Post,et al.  American College of Surgeons , 2020, Definitions.

[229]  Benjamin Haibe-Kains,et al.  Inconsistency in large pharmacogenomic studies , 2013, Nature.

[230]  Andrew H. Beck,et al.  PharmacoGx: an R package for analysis of large pharmacogenomic datasets , 2015, Bioinform..

[231]  P. Hieter,et al.  Synthetic lethality and cancer , 2017, Nature Reviews Genetics.

[232]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[233]  J. Manson,et al.  Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. , 2016, Cancer research.

[234]  E. Hall,et al.  Radiation oncology: a century of achievements , 2004, Nature Reviews Cancer.

[235]  Steven J. M. Jones,et al.  Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients , 2018, Cancer cell.

[236]  Oladimeji Farri,et al.  Comparative effectiveness of convolutional neural network (CNN) and recurrent neural network (RNN) architectures for radiology text report classification , 2019, Artif. Intell. Medicine.

[237]  C. Zahnow,et al.  Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. , 2017, Cancer discovery.

[238]  Kam Y. J. Zhang,et al.  Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma , 2010, Nature.

[239]  William R. Hogan,et al.  Natural Language Processing methods and systems for biomedical ontology learning , 2011, J. Biomed. Informatics.

[240]  Deborah Hix,et al.  The immune epitope database (IEDB) 3.0 , 2014, Nucleic Acids Res..

[241]  Chao Yang,et al.  A Survey on Deep Transfer Learning , 2018, ICANN.

[242]  Jean-Pierre Gillet,et al.  The clinical relevance of cancer cell lines. , 2013, Journal of the National Cancer Institute.

[243]  L. Robison,et al.  Breast cancer and other second neoplasms after childhood Hodgkin's disease. , 1996, The New England journal of medicine.

[244]  K. Fujii,et al.  Possibility of using laser spectroscopy for the intraoperative detection of nonfluorescing brain tumors and the boundaries of brain tumor infiltrates. Technical note. , 2006, Journal of neurosurgery.

[245]  S. Gudbjörnsdottir,et al.  Pattern of increasing HbA1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer – a population-based nationwide case-control study , 2015, Acta oncologica.

[246]  Timothy Miller,et al.  A BERT-based Universal Model for Both Within- and Cross-sentence Clinical Temporal Relation Extraction , 2019, Proceedings of the 2nd Clinical Natural Language Processing Workshop.

[247]  G. Linette,et al.  Neoantigen Vaccines Pass the Immunogenicity Test. , 2017, Trends in molecular medicine.

[248]  Jean-Emmanuel Bibault,et al.  Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review , 2013, Cancer and Metastasis Reviews.

[249]  L. Cantley,et al.  The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment , 2018, Cell.

[250]  Olivier Elemento,et al.  Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome , 2019, BMC Bioinformatics.

[251]  Dina Demner-Fushman,et al.  Automated classification of eligibility criteria in clinical trials to facilitate patient-trial matching for specific patient populations , 2017, J. Am. Medical Informatics Assoc..

[252]  J. Marine,et al.  p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib. , 2016, European journal of cancer.

[253]  M. Cabana,et al.  Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. , 2019, JAMA.

[254]  J. Sidney,et al.  Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity , 2014, The Journal of experimental medicine.

[255]  Kirk Roberts,et al.  A FrameNet for Cancer Information in Clinical Narratives: Schema and Annotation , 2018, LREC.

[256]  Gabriela Alexe,et al.  Characterizing genomic alterations in cancer by complementary functional associations , 2016, Nature Biotechnology.

[257]  G. Ottaviani,et al.  The epidemiology of osteosarcoma. , 2009, Cancer treatment and research.

[258]  Ziding Feng,et al.  Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. , 2018, Gastroenterology.

[259]  Hiroshi Iseki,et al.  Precise comparison of protoporphyrin IX fluorescence spectra with pathological results for brain tumor tissue identification , 2011, Brain Tumor Pathology.

[260]  L. Wessels,et al.  Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients , 2015, Clinical Cancer Research.

[261]  Francisco Azuaje,et al.  Computational models for predicting drug responses in cancer research , 2016, Briefings Bioinform..

[262]  Scott E. Martin,et al.  Reproducible pharmacogenomic profiling of cancer cell line panels , 2016, Nature.

[263]  M. Stratton,et al.  Clock-like mutational processes in human somatic cells , 2015, Nature Genetics.

[264]  X. Xie,et al.  Rapid, Label-Free Detection of Brain Tumors with Stimulated Raman Scattering Microscopy , 2013, Science Translational Medicine.

[265]  O. Lund,et al.  NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.

[266]  Z. Szallasi,et al.  Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.

[267]  J. Greenbaum,et al.  Improved methods for predicting peptide binding affinity to MHC class II molecules , 2018, Immunology.

[268]  Raymond M. Moore,et al.  Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer , 2018, JAMA.

[269]  S. Salzberg,et al.  StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.

[270]  U. Şahin,et al.  Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices , 1999, Nature Biotechnology.

[271]  George Coukos,et al.  Mass spectrometry-based antigen discovery for cancer immunotherapy. , 2016, Current opinion in immunology.

[272]  S. Altekruse,et al.  Outcomes for children and adolescents with cancer: challenges for the twenty-first century. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[273]  Marcia Irene Canto,et al.  Screening for Pancreatic Cancer. , 2016, The Surgical clinics of North America.

[274]  Carol Friedman,et al.  A broad-coverage natural language processing system , 2000, AMIA.

[275]  Martin F. Cohen,et al.  Impact of the HITECH financial incentives on EHR adoption in small, physician-owned practices , 2016, Int. J. Medical Informatics.

[276]  Paul G. Thomas,et al.  Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses , 2019, Science Translational Medicine.

[277]  L. Bullinger,et al.  The patients’ view: impact of the extent of resection, intraoperative imaging, and awake surgery on health-related quality of life in high-grade glioma patients—results of a multicenter cross-sectional study , 2017, Neurosurgical Review.

[278]  M. Bernstein,et al.  The role of 5‐aminolevulinic acid in enhancing surgery for high‐grade glioma, its current boundaries, and future perspectives: A systematic review , 2016, Cancer.

[279]  Mihai Surdeanu,et al.  The Stanford CoreNLP Natural Language Processing Toolkit , 2014, ACL.

[280]  Chen Lin,et al.  Neural Temporal Relation Extraction , 2017, EACL.

[281]  Sunghwan Sohn,et al.  Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications , 2010, J. Am. Medical Informatics Assoc..

[282]  María Martín,et al.  Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..

[283]  F. Pirouzmand,et al.  Comparison of the reliability of brain lesion localization when using traditional and stereotactic image-guided techniques: a prospective study. , 2005, Journal of neurosurgery.

[284]  Serena Nik-Zainal,et al.  Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.

[285]  Chen Lin,et al.  Multilayered temporal modeling for the clinical domain , 2016, J. Am. Medical Informatics Assoc..

[286]  Pedro J Ballester,et al.  Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression data , 2016, bioRxiv.

[287]  Hong-Jun Yoon,et al.  Deep Learning for Automated Extraction of Primary Sites From Cancer Pathology Reports , 2018, IEEE Journal of Biomedical and Health Informatics.

[288]  Girish Chavan,et al.  NOBLE – Flexible concept recognition for large-scale biomedical natural language processing , 2016, BMC Bioinformatics.

[289]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[290]  D. Silverman,et al.  Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts. , 2015, American journal of epidemiology.

[291]  F. Rodriguez,et al.  Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival , 2017, Journal of Neuro-Oncology.

[292]  C. Harris A delayed complication of cancer therapy--cancer. , 1979, Journal of the National Cancer Institute.

[293]  Nicolai J. Birkbak,et al.  Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis. , 2017, The Lancet. Oncology.

[294]  Benjamin Schubert,et al.  FRED 2: an immunoinformatics framework for Python , 2016, Bioinform..

[295]  Chen Lin,et al.  Self-training improves Recurrent Neural Networks performance for Temporal Relation Extraction , 2018, Louhi@EMNLP.

[296]  Jennifer L. Lund,et al.  Comparison of SEER Treatment Data With Medicare Claims , 2016, Medical care.

[297]  N. McGranahan,et al.  Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.

[298]  Geoffrey E. Hinton,et al.  Learning representations by back-propagating errors , 1986, Nature.

[299]  W. Dupont Converting relative risks to absolute risks: a graphical approach. , 1986, Statistics in medicine.

[300]  Brent S. Pedersen,et al.  Combating subclonal evolution of resistant cancer phenotypes , 2017, Nature Communications.

[301]  Morten Nielsen,et al.  Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan , 2008, PLoS Comput. Biol..

[302]  Morten Nielsen,et al.  NetMHCcons: a consensus method for the major histocompatibility complex class I predictions , 2011, Immunogenetics.

[303]  D. Kozieł,et al.  KRAS, KIT and TP53 mutations in mother’s and daughter’s gastric cardia adenocarcinomas , 2018, Przeglad gastroenterologiczny.

[304]  M. Korc,et al.  Circulating Leptin and Branched Chain Amino Acids—Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade , 2018, Journal of Gastrointestinal Surgery.

[305]  Marie-Francine Moens,et al.  Word-Level Loss Extensions for Neural Temporal Relation Classification , 2018, COLING.

[306]  A. Pappo,et al.  Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[307]  A. Gelrud,et al.  Predictors for Pancreatic Cancer Diagnosis Following New-Onset Diabetes Mellitus , 2015, Clinical and translational gastroenterology.

[308]  K Tashibu [Analysis of water content in rat brain using Raman spectroscopy]. , 1990, No to shinkei = Brain and nerve.

[309]  Javier A. Jo,et al.  Blind End-Member and Abundance Extraction for Multispectral Fluorescence Lifetime Imaging Microscopy Data , 2014, IEEE Journal of Biomedical and Health Informatics.

[310]  Tormod Selbekk,et al.  Comparison of navigated 3D ultrasound findings with histopathology in subsequent phases of glioblastoma resection , 2008, Acta Neurochirurgica.

[311]  K. Lillemoe,et al.  Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer , 1999, British Journal of Cancer.

[312]  E. Mardis,et al.  pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens , 2016, Genome Medicine.

[313]  S. Bertolone,et al.  Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience , 2014, Pediatric blood & cancer.

[314]  Yong-Chen Lu,et al.  Targeting neoantigens for cancer immunotherapy. , 2016, International immunology.

[315]  Y. Hoshida,et al.  Cancer biomarker discovery and validation. , 2015, Translational cancer research.

[316]  Steven J. M. Jones,et al.  Comprehensive Characterization of Cancer Driver Genes and Mutations , 2018, Cell.

[317]  Aman N. Patel,et al.  CONSERTING: integrating copy-number analysis with structural-variation detection , 2015, Nature Methods.

[318]  Steven J. M. Jones,et al.  The Immune Landscape of Cancer , 2018, Immunity.

[319]  Adam A. Margolin,et al.  Population-level distribution and putative immunogenicity of cancer neoepitopes , 2017, BMC Cancer.

[320]  Kevin Petrecca,et al.  A new method using Raman spectroscopy for in vivo targeted brain cancer tissue biopsy , 2018, Scientific Reports.

[321]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[322]  Alfredo Quinones-Hinojosa,et al.  ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME , 2009, Neurosurgery.

[323]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[324]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[325]  Huitu Liu,et al.  MAPK signal pathways in the regulation of cell proliferation in mammalian cells , 2002, Cell Research.

[326]  Matthew Scotch,et al.  The Yale cTAKES extensions for document classification: architecture and application , 2011, J. Am. Medical Informatics Assoc..

[327]  Frank Noé,et al.  Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation , 2017, Front. Immunol..

[328]  Morten Nielsen,et al.  Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method , 2007, BMC Bioinformatics.

[329]  P. Tamayo,et al.  A genetic basis for the variation in the vulnerability of cancer to DNA damage , 2016, Nature Communications.

[330]  Morten Nielsen,et al.  Gapped sequence alignment using artificial neural networks: application to the MHC class I system , 2016, Bioinform..

[331]  C. D. Gelatt,et al.  Optimization by Simulated Annealing , 1983, Science.

[332]  Zhigang Duan,et al.  Limits of observational data in determining outcomes from cancer therapy , 2008, Cancer.

[333]  Mechthild Krause,et al.  Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.

[334]  Jennifer B Dennison,et al.  A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer , 2018, Journal of the National Cancer Institute.

[335]  Alessandro Sette,et al.  The Immune Epitope Database 2.0 , 2009, Nucleic Acids Res..

[336]  Ming Liu,et al.  Accuracy of Raman spectroscopy in differentiating brain tumor from normal brain tissue , 2017, Oncotarget.

[337]  Morten Nielsen,et al.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery , 2010, Immunology.

[338]  H. El‐Serag,et al.  A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women , 2018, Cancer medicine.

[339]  Yoav Goldberg,et al.  A Primer on Neural Network Models for Natural Language Processing , 2015, J. Artif. Intell. Res..

[340]  John F. Canny,et al.  A Computational Approach to Edge Detection , 1986, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[341]  W. Hahn,et al.  Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer , 2018, Genetics in Medicine.

[342]  David Boulware,et al.  A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. , 2009, International journal of radiation oncology, biology, physics.

[343]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[344]  Martín Abadi,et al.  TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems , 2016, ArXiv.

[345]  Graham A. Colditz,et al.  The Nurses' Health Study: lifestyle and health among women , 2005, Nature Reviews Cancer.

[346]  S. Joshua Swamidass,et al.  Accounting for proximal variants improves neoantigen prediction , 2018, Nature Genetics.

[347]  Eric Fosler-Lussier,et al.  Identification, characterization, and grounding of gradable terms in clinical text , 2016, BioNLP@ACL.

[348]  David K. Vawdrey,et al.  HARVEST, a longitudinal patient record summarizer , 2014, J. Am. Medical Informatics Assoc..

[349]  Morten Nielsen,et al.  Dataset size and composition impact the reliability of performance benchmarks for peptide-MHC binding predictions , 2014, BMC Bioinformatics.

[350]  Robert Budden,et al.  TCGA Expedition: A Data Acquisition and Management System for TCGA Data , 2016, PloS one.

[351]  Timothy A. Miller,et al.  DeepPhe: A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records. , 2017, Cancer research.

[352]  S. Liyanarachchi,et al.  MicroRNA-3151 inactivates TP53 in BRAF-mutated human malignancies , 2015, Proceedings of the National Academy of Sciences.

[353]  A. Oshlack,et al.  JAFFA: High sensitivity transcriptome-focused fusion gene detection , 2015, Genome Medicine.

[354]  G. Petersen,et al.  Familial Pancreatic Adenocarcinoma. , 2015, Hematology/oncology clinics of North America.

[355]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[356]  Christopher A. Miller,et al.  Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy. , 2016, Cancer discovery.

[357]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[358]  Young Saing Kim,et al.  Concordance Rate between Clinicians and Watson for Oncology among Patients with Advanced Gastric Cancer: Early, Real-World Experience in Korea , 2019, Canadian journal of gastroenterology & hepatology.

[359]  T. Kietzmann,et al.  Antioxidant responses and cellular adjustments to oxidative stress , 2015, Redox biology.

[360]  A. Stewart,et al.  Comparison of Cases Captured in the National Cancer Data Base with Those in Population-based Central Cancer Registries , 2013, Annals of surgical oncology.

[361]  Jürgen Schmidhuber,et al.  Long Short-Term Memory , 1997, Neural Computation.

[362]  John F. Hurdle,et al.  Extracting Information from Textual Documents in the Electronic Health Record: A Review of Recent Research , 2008, Yearbook of Medical Informatics.

[363]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[364]  Sherri Rose,et al.  Classifying Lung Cancer Severity with Ensemble Machine Learning in Health Care Claims Data , 2017, MLHC.

[365]  Pierre Zweigenbaum,et al.  Clinical Natural Language Processing in languages other than English: opportunities and challenges , 2018, Journal of Biomedical Semantics.

[366]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[367]  Morten Nielsen,et al.  NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction , 2009, BMC Bioinformatics.

[368]  Knut Reinert,et al.  Flexbar 3.0 ‐ SIMD and multicore parallelization , 2017, Bioinform..

[369]  Mitchell H Gail,et al.  On criteria for evaluating models of absolute risk. , 2005, Biostatistics.

[370]  J. Manson,et al.  Inflammatory Plasma Markers and Pancreatic Cancer Risk: A Prospective Study of Five U.S. Cohorts , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[371]  Pengfei Li,et al.  MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation* , 2009, Journal of Biological Chemistry.

[372]  Christian Wiesmann,et al.  Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. , 2009, The Journal of clinical investigation.

[373]  S. Nelson,et al.  Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.

[374]  Steven Bethard,et al.  Efficient identification of nationally mandated reportable cancer cases using natural language processing and machine learning , 2016, J. Am. Medical Informatics Assoc..

[375]  F. Bova,et al.  The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. , 2017, Journal of neurosurgery.

[376]  Fan Zhang,et al.  Syn-Lethality: An Integrative Knowledge Base of Synthetic Lethality towards Discovery of Selective Anticancer Therapies , 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine.

[377]  J. Gartner,et al.  Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers , 2019, The Journal of clinical investigation.

[378]  Pascal Vincent,et al.  Representation Learning: A Review and New Perspectives , 2012, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[379]  Mariza de Andrade,et al.  Probability of pancreatic cancer following diabetes: a population-based study. , 2005, Gastroenterology.

[380]  Alessandro Sette,et al.  The Immune Epitope Database (IEDB): 2018 update , 2018, Nucleic Acids Res..

[381]  G A Colditz,et al.  Physical activity, obesity, height, and the risk of pancreatic cancer. , 2001, JAMA.

[382]  Drew J. Adams,et al.  Radiotherapy in the Era of Precision Medicine. , 2015, Seminars in radiation oncology.

[383]  Mikael Karlsson,et al.  The effects of hypoxia on the theoretical modelling of tumour control probability , 2005, Acta oncologica.

[384]  I. Lewis,et al.  Osteosarcoma treatment - where do we stand? A state of the art review. , 2014, Cancer treatment reviews.

[385]  Clemencia Pinilla,et al.  Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior , 2009, BMC Bioinformatics.

[386]  Francesco Iorio,et al.  Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy , 2016, Scientific Reports.

[387]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[388]  Mingming Jia,et al.  COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..

[389]  Benjamin Haibe-Kains,et al.  Genomic biomarkers for precision radiation medicine. , 2017, The Lancet. Oncology.

[390]  Michele A. Busby,et al.  Supplementary Materials for Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification , 2018 .

[391]  Alfredo Quinones-Hinojosa,et al.  The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? , 2014, Journal of Neuro-Oncology.

[392]  Jun S. Liu,et al.  Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies. , 2018, Cell systems.

[393]  Naoaki Okazaki,et al.  Investigating the Challenges of Temporal Relation Extraction from Clinical Text , 2018, Louhi@EMNLP.

[394]  Regina Barzilay,et al.  Using machine learning to parse breast pathology reports , 2016, bioRxiv.

[395]  Franck Dernoncourt,et al.  Comparing deep learning and concept extraction based methods for patient phenotyping from clinical narratives , 2018, PloS one.

[396]  Diana Tichy,et al.  Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC–Peptide Binding Data Set , 2019, Cancer Immunology Research.

[397]  Christopher A. Miller,et al.  Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases , 2016, PLoS medicine.

[398]  Cong Liu,et al.  [Functional Analysis of DNA Damage Repair Factor WDR70 and Its Mutation in Ovarian Cancer]. , 2016, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[399]  N. Hacohen,et al.  HLA-Binding Properties of Tumor Neoepitopes in Humans , 2014, Cancer Immunology Research.

[400]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[401]  Tomas Mikolov,et al.  Bag of Tricks for Efficient Text Classification , 2016, EACL.

[402]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[403]  G. Steel,et al.  The radioresponsiveness of human tumours and the initial slope of the cell survival curve. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[404]  T. Ideker,et al.  MHC-I Genotype Restricts the Oncogenic Mutational Landscape , 2017, Cell.

[405]  Morten Nielsen,et al.  Automated benchmarking of peptide-MHC class I binding predictions , 2015, Bioinform..

[406]  Levi A Garraway,et al.  Genomics-driven oncology: framework for an emerging paradigm. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[407]  Patrick Aloy,et al.  Drug sensitivity in cancer cell lines is not tissue-specific , 2015, Molecular Cancer.

[408]  F. Wenz,et al.  Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization , 2016, International journal of molecular sciences.

[409]  K. Cibulskis,et al.  Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. , 2014, Blood.

[410]  Alison P. Klein,et al.  Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 , 2016, Oncotarget.

[411]  Karen Margolis,et al.  Disclosure of Potential Conflicts of Interest , 2014 .

[412]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[413]  Won-Suk Lee,et al.  Assessing Concordance With Watson for Oncology, a Cognitive Computing Decision Support System for Colon Cancer Treatment in Korea. , 2018, JCO clinical cancer informatics.

[414]  Eduard Schreibmann,et al.  Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery , 2016, Molecular Imaging and Biology.

[415]  Jing Ma,et al.  Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia , 2015, Nature Communications.

[416]  T. Bumgarner Pediatric And Adolescent Osteosarcoma , 2016 .

[417]  J P Freyer,et al.  Oxygen enhancement ratio as a function of dose and cell cycle phase for radiation-resistant and sensitive CHO cells. , 1991, Radiation research.

[418]  Michael R. Crusoe,et al.  Common Workflow Language , 2015 .

[419]  Hyun Cheol Chung,et al.  Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells , 2011, BMC Genomics.